Prolonged Anti-Hypertensive Effects of Oral Sitaxsentan, a Selective ETA Endothelin Receptor Antagonist, in Spontaneoulsy Hypertensive Hamsters

Author： Rubinstein Israel  

Publisher： Springer Publishing Company

ISSN： 0920-3206

Source： Cardiovascular Drugs and Therapy, Vol.20, Iss.5, 2006-10, pp. : 387-390

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sitaxsentan, a selective endothelin-A receptor antagonist for the treatment of pulmonary arterial hypertension

By Horn Evelyn M   Widlitz Allison C   Barst Robyn J  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 11, 2004-11 ,pp. : 1483-1492

Informa Healthcare

Access to resources Recommend Favorite

Differential haemodynamic effects of endothelin receptor antagonist, SB 209670, in conscious hypertensive and normotensive rats

By Bunting M.W.   Widdop R.E.  

European Journal of Pharmacology, Vol. 381, Iss. 1, 1999-09 ,pp. : 13-21

Elsevier

Access to resources Recommend Favorite

Anti-Hypertensive

By  

Current Bioactive Compounds, Vol. 2, Iss. 4, 2006-12 ,pp. : 492-492

Bentham Science Publishers

Access to resources Recommend Favorite

Ameliorating effect of an endothelin ET A receptor antagonist on renal function of DOCA-salt hypertensive rats

By Matsumura Y.   Hashimoto N.   Fujita K.   Morimoto S.  

European Journal of Pharmacology, Vol. 319, Iss. 1, 1997-01 ,pp. : 65-69

Elsevier

Access to resources Recommend Favorite

Hypertension, Anti-Hypertensive Therapy and Neoplasia

By  

Current Pharmaceutical Design, Vol. 13, Iss. 25, 2007-09 ,pp. : 2539-2544

Bentham Science Publishers

Access to resources Recommend Favorite